Source:http://linkedlifedata.com/resource/pubmed/id/12537978
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-1-22
|
pubmed:abstractText |
Sixteen mer peptide, which spans the junctional region of the acute lymphoid leukemia (ALL)-specific minor bcr-abl fusion protein and contains a motif that can bind to human leukocyte antigen (HLA)-A24, was constructed. We tried to generate Philadelphia chromosome 1 (Ph1) positive ALL-specific cytotoxic T lymphocytes (CTLs) from eight normal HLA-A24+ individuals with peptide-pulsed autologous dendritic cells (DCs). CTLs could be generated from the mononuclear cells (MNCs) of a single donor, which could kill peptide-pulsed autologous DCs and two A24+ ALL lines, while an HLA-A24+ CML line was only weakly killed and unpulsed DCs or the control lines Daudi or K562 were not recognized. Those CTLs consisted predominantly of CD8+ T cells whose cytotoxicity could be neutralized by monoclonal antibodies to HLA-class I or HLA-A24, and also produced interferon (IFN)-gamma after being stimulated with peptide-pulsed DCs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A24 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0145-2126
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
253-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12537978-Antigen Presentation,
pubmed-meshheading:12537978-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12537978-Coculture Techniques,
pubmed-meshheading:12537978-Cytotoxicity, Immunologic,
pubmed-meshheading:12537978-Dendritic Cells,
pubmed-meshheading:12537978-Fusion Proteins, bcr-abl,
pubmed-meshheading:12537978-HLA-A Antigens,
pubmed-meshheading:12537978-HLA-A24 Antigen,
pubmed-meshheading:12537978-Humans,
pubmed-meshheading:12537978-Interferon-gamma,
pubmed-meshheading:12537978-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:12537978-Oligopeptides,
pubmed-meshheading:12537978-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:12537978-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:12537978-Tumor Cells, Cultured
|
pubmed:year |
2003
|
pubmed:articleTitle |
The in vitro generation of Ph1+ ALL-specific HLA-A24-restricted cytotoxic T lymphocytes using a synthetic 16 mer minor bcr-abl peptide.
|
pubmed:affiliation |
Department of Hematology and Rheumatology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan. masaoha@is.icc.u-tokai.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|